![Use of Infliximab Biosimilar Versus Originator in a Paediatric United Kingdom Inflammatory Bowel Disease Induction Cohort]()
Use of Infliximab Biosimilar Versus Originator in a Paediatric United Kingdom Inflammatory Bowel Disease Induction CohortChanchlani, Neil; Mortier, Kajal; Williams, Linda J.; Muhammed, Rafeeq; Auth, Marcus K.H.; Cosgrove, Mike; Fagbemi, Andrew; Fell, John; Chong, Sonny; Zamvar, Veena; Hyer, Warren; Bisset, W. Michael; Morris, Mary-Anne; Rodrigues, Astor; Mitton, Sally G.; Bunn, Su; Beattie, R. Mark; Willmott, Anne; Wilson, David C.; Russell, Richard K. · Journal of Pediatric Gastroenterology and Nutrition · 2018